We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
MHRA advises parents and carers against using rectal catheters sold for personal use (known as gas and colic relievers) in babies.
MHRA publishes position paper clarifying the UK licencing route for microbiome-based medicines, supporting developers to bring these innovative therapies to patients.
As with any medicine, the MHRA will keep the safety and effectiveness of vimseltinib (romvizma) under close review.
An amber heat-health alert is now in place across all regions in England.
Medicines and medical devices regulator issues health advice for teens off to university.
While around 60% of women giving birth every month are vaccinated, UKHSA warns many thousands of babies still at risk.
Vaccination is one of the most effective and safest ways to protect against many serious infectious diseases
The MHRA has become aware of a number of medical devices being supplied on the UK market that do not comply with the requirements of the UK Medical Device Regulations or with the EU Medical Devices Regulation.
As with all GLP-1 receptor agonists, the MHRA will keep the safety and effectiveness of orforglipron under close review.
Some medicines can make you more sensitive to the sun or increase the risk of dehydration without you realising it. The MHRA is encouraging people to know the risks and stay protected this summer.
As with any medicinal product, the MHRA will keep the safety and effectiveness of remibrutinib under close review.
Infected Blood Compensation Authority's update that was circulated on 6 August 2026
£343 million plan will open 159 NHS mental health centres in England, giving people earlier local support and specialist crisis care outside A&E.
Health and Social Care Secretary announces faster access to care and support for motor neurone disease patients during a visit to the Rob Burrow Centre.
Innovative investigational products for liver cancer and dementia recognised through the Innovative Licensing and Access Pathway ahead of next application round opening.
The Infected Blood Memorial Committee hosted two webinars in July to update the community on their progress and to share their current thinking regarding the UK Memorial.
Urgent work to take place to protect bereaved families.
NHS trusts and construction partners have signed agreements to deliver the next phase of the New Hospital Programme.
Travellers urged to follow food and water hygiene advice to reduce risk of infection
Aficamten is recommended by NICE at the same time it was approved by the MHRA, thanks to improvements driven by closer working between the two organisations.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).